Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced Head-and-Neck Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05349045
What this trial is testing

Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
The First Affiliated Hospital of Zhengzhou University 300
Not applicableActive Not RecruitingNCT02945631
What this trial is testing

Quarterback 2b - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx Cancer

Who this might be right for
Locally Advanced HPV Positive Oropharynx Cancer
Icahn School of Medicine at Mount Sinai 43
Testing effectiveness (Phase 2)UnknownNCT02976051
What this trial is testing

DAHANCA 33: Image Guided Dose-escalated Radiotherapy to Patients With Hypoxic HNSCC

Who this might be right for
Locally Advanced Head and Neck CancerRadiotherapyHypoxic Radioresistance
Danish Head and Neck Cancer Group 60
Early research (Phase 1)Not Yet RecruitingNCT06491134
What this trial is testing

Liposomal Irinotecan With Cisplatin and Concurrent Radiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Hebei Medical University Fourth Hospital 12
Testing effectiveness (Phase 2)Study completedNCT02047201
What this trial is testing

Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Lithuanian University of Health Sciences 40
Testing effectiveness (Phase 2)Study completedNCT02562599
What this trial is testing

Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin

Who this might be right for
Nasopharyngeal Carcinoma
Hubei Cancer Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT07733830
What this trial is testing

Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCC

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 120
Large-scale testing (Phase 3)Looking for participantsNCT07371611
What this trial is testing

Sintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Oral Squamous Cell CarcinomaOral Squamous Cell Carcinoma (OSCC)
Qunxing Li,MD 104
Not applicableUnknownNCT05824312
What this trial is testing

HRQOL in Locally Advanced Thyroid Carcinoma

Who this might be right for
Thyroid CancerTyrosine Kinase InhibitorHealth Related Quality of Life
Fujian Cancer Hospital 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07797881
What this trial is testing

BL-B01D1 With or Without PD-1 Monoclonal Antibody in Patients With High-Risk Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma (NPC)
Sichuan Baili Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)WithdrawnNCT00233636
What this trial is testing

Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck CancerCarcinoma, Squamous Cell
AstraZeneca 28
Testing effectiveness (Phase 2)UnknownNCT05007145
What this trial is testing

PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Subjects With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal NeoplasmsEsophageal Squamous Cell Carcinoma
Fujian Cancer Hospital 92
Early research (Phase 1)Study completedNCT01334177
What this trial is testing

TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+38 more
University of Washington 13
Testing effectiveness (Phase 2)Ended earlyNCT00904345
What this trial is testing

Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (SCC)

Who this might be right for
Head and Neck Cancer
University of Michigan Rogel Cancer Center 23
Not applicableStudy completedNCT04733495
What this trial is testing

Group-Mediated Cognitive Behavioral Resistance Exercise Intervention in Head and Neck Cancer Patients Undergoing Chemoradiation Treatment

Who this might be right for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Ohio State University Comprehensive Cancer Center 20
Testing effectiveness (Phase 2)UnknownNCT05476380
What this trial is testing

Neoadjuvant Therapy of Camrelizumab Combined With Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Carcinoma
Tianjin Medical University Cancer Institute and Hospital 39
Early research (Phase 1)Active Not RecruitingNCT03821935
What this trial is testing

Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 364
Testing effectiveness (Phase 2)Looking for participantsNCT06940180
What this trial is testing

Toripalimab With Chemotherapy for Sinus Cancer

Who this might be right for
Sinonasal CancerParanasal Sinus NeoplasmsSquamous Cell Carcinoma+2 more
Dana-Farber Cancer Institute 20
Not applicableStudy completedNCT03047174
What this trial is testing

Radiotherapy Related Skin Toxicity: Mepitel® vs. Standard Care in Patients With Locally Advanced Head-and-Neck Cancer

Who this might be right for
Head and Neck Neoplasms
University Hospital Schleswig-Holstein 57
Testing effectiveness (Phase 2)Study completedNCT00721513
What this trial is testing

Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Wake Forest University Health Sciences 20
Next Page